Schroders Cap Glbl - Sale of Tessian
31/10/2023 12:56
For best results when printing this announcement, please click on link below: http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231031:nRSe8997Ra&default-theme=true RNS Number : 8997R Schroders Capital Global Innovation 31 October 2023 Schroders Capital Global Innovation Trust plc Sale of Tessian Schroders Capital Global Innovation Trust plc (the "Company") announces that its portfolio company Tessian, the innovative email cybersecurity company, has entered into a definitive agreement to be acquired by Proofpoint - a people-centric cybersecurity and compliance company. The agreement is expected to close in late 2023 to early 2024, subject to customary closing conditions and required regulatory approvals. Details of the transaction were not disclosed. In May 2021, the Company made a $6.75m investment into Tessian as part of its $65m Series C funding round to accelerate its mission of quantifying and preventing human risk in enterprises across the globe. Tessian's Series C round was led by March Capital, a U.S.-based venture capital and growth equity firm, with participation from existing shareholders including Sequoia Capital, Accel, Balderton Capital and Latitude. Tim Creed, Lead Portfolio Manager, and Harry Raikes, Co-Portfolio Manager commented: " It has been a pleasure working closely with Tim Sadler, CEO, and the Tessian team over the past two years and we wish them all the best in their next chapter. We hope to be able to share more details with the Company's investors when the transaction closes." Enquiries: Schroder Investment Management Limited Shilla Pindoria (Company Secretary) 0207 658 6000 Augustine Chipungu (Press) 0207 658 2106 John Spedding (Head of Investment Trusts) 0207 658 3206 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com (mailto:rns@lseg.com) or visit www.rns.com (http://www.rns.com/) . RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy) . END DISFLFEFISLLVIV